Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Lilly reports encouraging trial results for its next-gen GLP-1 shot

Patients taking the highest dose of retatrutide lost 16.8% of their body weight after 40 weeks, more than its current bestseller, tirzepatide.

J. Edward Moreno
Author: J. Edward Moreno

Written by

J. Edward Moreno

in

Business
←WATCH: Best friends of 50 years go viral after one shares cancer journey
21 Essential Books That Fiercely Celebrate Black Womanhood→

More posts

  • Protesters, leaders push back against DHS over Newark detention facility conditions

  • Goldman and Lander spar hard over Israel

  • Snowflake climbs after Q1 results top expectations, guidance gets a boost

  • Synopsys drops despite better than expected Q2 results, big boost to full-year guidance

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube